Debate on E-cigarette Regulation: UK Parliament vs. WHO

Regulations by 2FIRSTS.ai
Jan.18.2024
Debate on E-cigarette Regulation: UK Parliament vs. WHO
UK Parliament plans to livestream a debate on January 18th regarding e-cigarette regulations, the WHO COP10, and differing stances on e-cigarettes.

The British Parliament is set to hold a live debate on January 18th, focusing on the regulation of e-cigarettes in the country, the upcoming tenth session of the Conference of the Parties (COP10) to the World Health Organization's Framework Convention on Tobacco Control in Panama, and the differing positions of this organization and the UK government regarding e-cigarettes. This debate, initiated by MP Andrew Lewer, aims to examine and challenge the WHO's opposition to e-cigarettes, particularly their policies on banning or overly regulating e-cigarettes, heated tobacco products, and oral nicotine pouches.

 

The World Health Organization (WHO) has long been committed to controlling the use of tobacco and nicotine products, especially e-cigarettes. According to a report on December 14, 2023, the WHO emphasized the need for urgent action to control e-cigarettes in order to protect children and non-smokers, while minimizing the health risks to the public. The WHO pointed out that e-cigarettes contain highly addictive nicotine and are harmful to health.

 

Meanwhile, the stance of the United Kingdom differs significantly from that of the World Health Organization (WHO). The UK government has consistently supported e-cigarettes as a substitute for reducing the harm caused by smoking. According to the UK government's perspective, e-cigarettes can aid smokers in quitting, and their risks are far lower than those associated with traditional tobacco products. A report by the Policy Exchange, a UK policy think tank, demonstrates the enormous impact smoking has on the economy and highlights that reducing smoking rates can not only improve health conditions and alleviate the burden on the National Health Service (NHS) but also stimulate productivity and economic growth.

 

The upcoming debate in the British Parliament is expected to cover various areas, including concerns about the influence of the World Health Organization (WHO) on UK health policies and calls for the UK delegation to uphold its stance on the role of e-cigarettes in smoking cessation on the international stage.

 

The parliamentary debate in the UK has presented a rare opportunity for the public to gain insight into the controversy and intricacies surrounding e-cigarettes within the global tobacco control movement. This debate is expected to offer novel perspectives on the future development of global tobacco control policies.

 

2FIRSTS will be providing full coverage of the entire debate and will provide further updates after its conclusion. Stay tuned for more information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Product | VEEV One Plus Goes Official as PMI Strengthens Its Closed-Pod Vaping Portfolio
Product | VEEV One Plus Goes Official as PMI Strengthens Its Closed-Pod Vaping Portfolio
Philip Morris International (PMI) has officially introduced the VEEV One Plus, the next-generation device in its closed-pod vaping lineup. The product is now featured on the official VEEV website in Portugal, bringing hardware upgrades including a new dual-pod storage system, a larger battery, and an updated device design while maintaining compatibility with existing VEEV One pods.
Jul.02
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Several European sports outlets have reported on a suspected nicotine pouch seen in French footballer Michael Olise’s locker photo, bringing football’s long-running “snus” culture back into public view and highlighting brand visibility, product classification and public-health debate around nicotine pouches in sports settings.
News
Jun.25 by 2Firsts Perspectives
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25